The EGF signaling pathway influences cell migration and the secretion of metalloproteinases by myoepithelial cells in pleomorphic adenoma
Tóm tắt
During tumor development, benign neoplastic cells are influenced by the expression of cytokines, growth factors, and proteases present in the tumor microenvironment. Epidermal growth factor (EGF) is the most studied growth factor and is considered important for cell proliferation and migration. Metalloproteinases (MMPs) are also involved in tumor progression. The present study aimed to analyze the proliferation, viability and migration index of pleomorphic adenoma myoepithelial cells, in addition to the secretion of MMPs with EGF supplementation. Benign myoepithelial cells were cultured with two different EGF doses (5 and 10 ng/ml), and the influence of EGF on cell proliferation and viability, using trypan blue and MTT assays, respectively, after 24, 48, and 72 h, was evaluated. To analyze cellular morphology, hematoxylin-eosin staining and indirect immunofluorescence using the anti-vimentin antibody, was performed. In vitro migration assays were performed in Transwell chambers with an 8-μm pore covered with Matrigel and supplemented with 5 or 10 ng/ml of EGF, after 96 h. After 4 days of cell culture, ELISA was performed to determine the MMP-2 and MMP-13 levels. One-way analysis of variance (ANOVA) with post hoc Tukey test was applied, with a significance level of 0.05. The results revealed that EGF influences myoepithelial cell morphology, without alteration of proliferation and viability. The migration assay showed that EGF increased the mean index from 16 % in the control group to 40 and 76 % for 5 and 10 ng/ml of EGF, respectively. ELISA revealed that when the cells were supplemented with either of the EGF doses, an increase in MMP-2 levels was observed when compared with the control group (C). This study concludes that EGF aids in the production of MMP-2, which favors the dissolution of the basement membrane, contributing to cell migration and tumor progression, hence permitting contact between the myoepithelial cells and stroma.
Tài liệu tham khảo
Bissell MJ, Kenny PA, Radisky DC. Microenvironmental regulators of tissue structure and function also regulate tumor induction and progression: the role of extracellular matrix and its degrading enzymes. Cold Spring Harb Symp Quant Biol. 2005;70:343–56.
Jorissen RN, Walker F, Pouliot N, Garrett TP, Ward CW, Burgess AW. Epidermal growth factor receptor: mechanisms of activation and signalling. Exp Cell Res. 2003;284(1):31–53.
Henson ES, Gibson SB. Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: implications for cancer therapy. Cell Signal. 2006;18(12):2089–97.
Martinez EF, Demasi AP, Miguita L, Altemani A, Araújo NS, Araújo VC. FGF-2 is overexpressed in myoepithelial cells of carcinoma ex-pleomorphic adenoma in situ structures. Oncol Rep. 2010;24(1):155–60.
Martinez EF, Demasi AP, Napimoga MH, Arana-Chavez VE, Altemani A, de Araújo NS, et al. In vitro influence of the extracellular matrix in myoepithelial cells stimulated by malignant conditioned medium. Oral Oncol. 2012;48(2):102–9.
McSherry EA, Donatello S, Hopkins AM, McDonnell S. Molecular basis of invasion in breast cancer. Cell Mol Life Sci. 2007;64(24):3201–18.
Kumar S, Weaver VM. Mechanics, malignancy, and metastasis: the force journey of a tumor cell. Cancer Metastasis Rev. 2009;28(1–2):113–27.
Martinez EF, Napimoga MH, Montalli VA, de Araújo NS, de Araújo VC. In vitro cytokine expression in in situ-like areas of malignant neoplasia. Arch Oral Biol. 2013;58(5):552–7.
Yamahara M, Fujito T, Ishikawa T, Shimosato T, Yokozaki H, Yasui W, et al. Phenotypic expression of human epidermal growth factor in foetal submandibular gland and pleomorphic adenoma of salivary gland. Virchows Arch A Pathol Anat Histopathol. 1988;412(4):301–6.
Umeda Y, Miyazaki Y, Shiinoki H, Higashiyama S, Nakanishi Y, Hieda Y. Involvement of heparin-binding EGF-like growth factor and its processing by metalloproteinases in early epithelial morphogenesis of the submandibular gland. Dev Biol. 2001;237(1):202–11.
Nitta M, Kume T, Nogawa H. FGF alters epithelial competence for EGF at the initiation of branching morphogenesis of mouse submandibular gland. Dev Dyn. 2009;238(2):315–23.
Antoniades HN, Owen AJ. Growth factors and regulation of cell growth. Annu Rev Med. 1982;33:445–63.
Mendelsohn J, Baselga J. The EGF receptor family as targets for cancer therapy. Oncogene. 2000;19(56):6550–65.
Harari PM. Epidermal growth factor receptor inhibition strategies in oncology. Endocr Relat Cancer. 2004;11:689–708.
Furuse C, Miguita L, Rosa AC, Soares AB, Martinez EF, Altemani A, et al. Study of growth factors and receptors in carcinoma ex pleomorphic adenoma. J Oral Pathol Med. 2010;39(7):540–7.
Sabe H, Hashimoto S, Morishige M, Hashimoto A, Ogawa E. The EGFR-GEP100-Arf6 pathway in breast cancer: full invasiveness is not from the inside. Cell Adh Migr. 2008;2(2):71–3.
Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res. 2006;69:562–73.
Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodeling. Nat Rev Mol Cell Biol. 2007;8:221–33.
Decock J, Thirkettle S, Wagstaff L, Edwards DR. Matrix metalloproteinases: protective roles in cancer. J Cell Mol Med. 2011;15(6):1254–65.
Huang CH, Yang WH, Chang SY, Tai SK, Tzeng CH, Kao JYK, et al. Regulation of membrane- type 4 matrix metalloproteinases by SLUG contributes to hypoxia-mediated metastasis. Neoplasia. 2009;11:1371–82.
Jones JL, Shaw JA, Pringle JH, Walker RA. Primary breast myoepithelial cells exert an invasion-suppressor effect on breast cancer cells via paracrine down-regulation of MMP expression in fibroblasts and tumour cells. J Pathol. 2003;201(4):562–72.
Sutinen M, Kainulainen T, Hurskainen T, Vesterlund E, Alexander JP, Overall CM, et al. Expression of matrix metalloproteinases (MMP-1 and MMP-2) and their inhibitors (TIMP-1, 2 and 3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymphonode metastasis. Br J Cancer. 1998;77(12):2239–45.
Gialeli C, Theocharis AD, Karamanos NK. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J. 2011;278:16–27.
Khasigov PZ, Podobed OV, Gracheva TS, Salbiev KD, Grachev SV, Berezov TT. Role of matrix metalloproteinases and their inhibitors in tumor invasion and metastasis. Biochemistry (Mosc). 2003;68(7):711–7.
Miguita L, Martinez EF, de Araújo NS, de Araújo VC. FGF-2, TGFbeta-1, PDGF-A and respective receptors expression in pleomorphic adenoma myoepithelial cells: an in vivo and in vitro study. J Appl Oral Sci. 2010;18(1):83–91.
Martinez EF, Montaldi PT, de Araújo NS, Altemani A, de Araújo VC. A proposal of an in vitro model which mimics in situ areas of carcinoma. J Cell Commun Signal. 2012;6(2):107–9.
Jones JL, Royal JE, Critchley DR, Walker RA. Modulation of myoepithelial-associated α6β4 integrin in a breast cancer cell line alters invasive potential. Exp Cell Res. 1997;235:325–33.
Barsky SH, Karlin NJ. Mechanisms of disease: breast tumor pathogenesis and the role of the myoepithelial cell. Nat Clin Pract Oncol. 2006;3(3):138–51.
Myoken Y, Myoken Y, Okamoto T, Sato JD, Kan M, McKeehan WL, et al. Immunohistochemical localization of fibroblast growth factor-1 (FGF-1), FGF-2 and fibroblast growth factor receptor-1 (FGFR-1) in pleomorphic adenoma of the salivary glands. J Oral Pathol Med. 1997;26(1):17–22.
Demasi AP, Furuse C, Soares AB, Altemani A, Araújo VC. Peroxiredoxin I, platelet- derived growth factor A, and platelet-derived growth factor receptor alpha are overexpressed in carcinoma ex-pleomorphic adenoma: association with malignant transformation. Hum Pathol. 2009;40(3):390–7.
Kagami H, Hiramatsu Y, Hishida S, Okazaki Y, Horie K, Oda Y, et al. Salivary growth factors in health and disease. Adv Dent Res. 2000;14:99–102.
Sredni B, Weil M, Khomenok G, Lebenthal I, Teitz S, Mardor Y, et al. Ammonium trichloro (dioxoethylene-o, o0) tellurate (AS101) sensitizes tumors to chemotherapy by inhibiting the tumor interleukin 10 autocrine loop. Cancer Res. 2004;64(5):1843–52.
Schneider MR, Wolf E. The epidermal growth factor receptor ligands at a glance. J Cell Physiol. 2009;218:460–6.
Yewale C, Baradia D, Vhora I, Patil S, Misra A. Epidermal growth factor recep- tor targeting in cancer: a review of trends and strategies. Biomaterials. 2013;34:8690–707.
Zeng F, Harris RC. Epidermal growth factor, from gene organization to bedside. Semin Cell Dev Biol. 2014;28C:2–11.
Moller P, Mechtersheimer G, Kaufmann M, Moldenhauer G, Momburg F, Mattfeldt T, et al. Expression of epidermal growth factor receptor in benign and malignant primary tumours of the breast. Virchows Arch A Pathol Anat Histopathol. 1989;414(2):157–64.
Santini D, Ceccarelli C, Tardio ML, Taffurelli M, Marrano D. Immunocytochemical expression of epidermal Growth factor receptor in myoepithelial cells of the breast. Appl Immunohistochem Mol Morphol. 2002;10(1):29–33.
Beil M, Micoulet A, von Wichert G, Paschke S, Walther P, Omary MB, et al. Sphingosyl phosphorylcholine regulates keratin network architecture and visco-elastic properties of human cancer cells. Nat Cell Biol. 2003;5:803–11.
Makarova G, Bette M, Schmidt A, Jacob R, Cai C, Rodepeter F, et al. Epidermal growth factor-induced modulation of cytokeratin expression levels influences the morphological phenotype of head and neck squamous cell carcinoma cells. Cell Tissue Res. 2013;351(1):59–72.
de Oliveira PT, Jaeger MM, Miyagi SP, Jaeger RG. The effect of a reconstituted basement membrane (Matrigel) on a human salivary gland myoepithelioma cell line. Virchows Arch. 2001;439(4):571–8.
Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002;2(3):161–74.
Bourboulia D, Stetler-Stevenson WG. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): positive and negative regulators in tumor cell adhesion. Semin Cancer Biol. 2010;20(3):161–8.
Hua H, Li M, Luo T, Yin Y, Jiang Y. Matrix metalloproteinases in tumorigenesis: an evolving paradigm. Cell Mol Life Sci. 2011;68(23):3853–68.
Ray JM, Stetler-Stevenson WG. Gelatinase A activity directly modulates melanoma cell adhesion and spreading. EMBO J. 1995;14:908–17.
Bergers G, Coussens LM. Extrinsic regulators of epithelial tumor progression: metalloproteinases. Curr Opin Genet Dev. 2000;10(1):120–7.
Lam RM. An electron microscopic histochemical study of the histogenesis of major salivary gland pleomorphic adenoma. Ultrastruct Pathol. 1985;8(2–3):207–23.